Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: Review of recent research strategies in depression

World Journal of Biological Psychiatry

Volumn 1, Issue 2, 2000, Pages 105-111

  Hatzinger, Martin ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXAMETHASONE; DIAGNOSTIC AGENT; GLUCOCORTICOID; NEUROPEPTIDE;

DRUG EFFECT; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; REVIEW;

ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0034175405     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970009150573     Document Type: Article

References (57)

1. Bleuler M (1954) Endokrinologische Psychiatrie. Thieme, Stuttgart.
2. Brady LS, Whitfeld Hj, Fox RJ, Cold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest 87:831-837.
3. Carroll BJ, Curtis CC, Davies BM, Mendels J, Sugerman AA (1976) Urinary free Cortisol excretion in depression. Psychol Med 6:43-50.
4. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James N, Kronfold Z, Lohr N, Steiner M, De Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15-22.
5. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
6. Chang CP, Pearse RV 2nd, O'Connell S, Rosenfeld MG (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195.
7. Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression and cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci 90:8967-8971.
8. De Bellis MD, Gold PW, Geracioti TD jr, Listwak SJ, Kling MA (1993) Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and argininevasopressin in patients with major depression. Am J Psychiatry 150:656-657.
9. De Goeij DC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJ (1991) Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin- releasing factor in the median eminence of rats. Neuroendocrinology 53:150-159.
10. De Kloet ER (1991) Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95-165.
11. De Kloet ER, Reul JMHM (1987) Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12:83-105.
12. Dunn AJ, Berridge CW (1990) Physiological and behavioral response to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress response? Barin Res Rev 15:71-100.
13. Gillies GE, Linton EA, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355-357.
14. Halbreich U, Asnis GM, Shindledecker R (1985) Cortisol secretion in endogenous depression. Arch Gen Psychiatry 42:904-908.
15. Hatzinger M, Reul JMHM, Landgraf R, Holsboer F, Neumann I (1996) Combined dexamethasone/CRH test in rats: Hypothalamopituitary-adrenocortical system alterations in aging. Neuroendocrinology 64:349-356.
16. Hatzinger M, Landgraf R, Holsboer F, Neumann I (1997) Involvement of vasopressin in hypothalamic-pituitary-adrenal system alterations. Europ Psychiatry 12(suppl 2):175S (abstract).
17. Hatzinger M, Wotjak CT, Naruo T, Simchen R, Keck ME, Landgraf R, Holsboer F, Neumann ID (2000) Endogenous vasopressin contributes to hypothalamic- pituitary-adrenocortical alterations in aged rats. J Endocrinol. 164:197-205
18. Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatry Res 28:341-356.
19. Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996) Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal comparison subjects. Am J Psychiatry 153:93-99.
20. Holsboer F (1999a) The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatry Res 33:181-214.
21. Holsboer F (1999b) Molekulare Mechanismen der Depressionstherapie. In: Ganten D, Ruckpaul K (eds) Handbuch der molekularen Medizin, Band 5. Springer, Berlin Heidelberg.
22. Holsboer F, Barden N (1996) Antidepressants and HPA regulation. Endocrine Rev 17:187-205.
23. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA (1984) Blunted corticotropin and normal Cortisol response to human corticotropin- releasing factor in depression. N Enql I Med 311:1127.
24. Holsboer F, Cerken A, Stalla CK, MüIIer OA (1987) Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am j Psychiatry 144:229-231.
25. Holsboer F, von Bardeleben U, Steiger A (1988) Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEC in man. Neuroendocrinology 48:32-38.
26. Holsboer F, Lauer CJ, Schreiber W, Krieg J-C (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340-347.
27. Holsboer-Trachsler E, Stohler R, Hatzinger M (1991) Repeated administration of the combined dexamethasone-human corticotropin-releasing hormone stimulation test during treatment of depression. Psychiatry Res 38:163-171.
28. Kalin NH (1990) Behavioral and endocrine studies of corticotropinreleasing hormone in primates. In: De Souza EB, Nemeroff CB (eds) Corticotropin-releasing factor: Basic and clinical studies of a neuropeptide. CRC Press, Boca Raton, pp 275-289.
29. Landgraf R (1995) Intracerebrally released vasopressin and oxytocin: measurements, mechanisms and behavioural consequences. J Neuroendocrinology 7:243-253.
30. Landgraf R, Cerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, Engelmann M (1995) V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities and anxiety-related behavior in rats. J Neurosci 15:4250-4258.
31. Liebsch C, Wotjak CT, Landgraf R, Engelmann M (1996) Septal vasopressin modulates anxiety-related behaviour in rats. Neuroscience letters 217:1-4.
32. Liebsch C, Landgraf R, Engelmann M, Lörscher P, Holsboer F (1999) Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain. J Psychiatric Res 33:153-163.
33. Linkowski P, Mendlewicz J, LeClerq R, Brasseur M, Hubain P, Goldstein J, Copinschi G, van Cauter E (1985) The 24-hour profile of ACTH and Cortisol in major depressive illness. J Clin Endocrinol Metab 61:429-438.
34. Lovenberg TW, Liaw ON, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sc USA 92:836-840.
35. Modell S, Yassouridis A, Huber J, Holsboer F (1997) Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65:216-222.
36. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg J-C, Holsboer F (1998) Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18:252-262.
37. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts DC, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
38. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579.
39. Nemeroff CB, Krishnan KRR, Reed D, Leder R, Beam C, Dunnick R (1992) Adrenal gland enlargement in major depression. Arch Gen Psychiatry 49:384-387.
40. Owens MJ, Nemeroff CB (1992) The physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473.
41. Purbaj S, Hoogendijk WJG, Hofman MA, Swaab DF (1996) Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53:137-143.
42. Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF (1994a) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:433-436.
43. Raadsheer FC, Oorschot DE, Verwer RWH, Tilders FJH, Swaab DF (1994) Age-related increase in the total number of corticotropinreleasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: Comparison of the disector with an unfolding method. J Comp Neurol 337:1-11.
44. Reul JMHM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:2505-2512.
45. Reul JMHM, van den Bosch FR, de Kloet ER (1987) Differential response of type I and type II corticosteroid receptor to changes in plasma steroid level and circadian rhythmicity. Neuroendocrinology 45:407-412.
46. Reul JMHM, Tonnaer JADM, de Kloet ER (1988) Neurotropic ACTH analog promotes plasticity of type I corticosteroid receptors in brain of senescent rats. Neurobiol Aging 9:253-260.
47. Reul JMHM, Rothuizen J, de Kloet ER (1991) Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: Neuroendocrine activity and corticosteroid receptors. J Steroid Biochem Mol Biol 40:63-69.
48. Reul JMHM, Stec I, Söder M, Holsboer F (1993) Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320.
49. Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F (1994) Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor modobemide. Neuroendocrinology 60:509 519.
50. Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995) Adrenal gland volume in major depression. Arch Gen Psychiatry 52:213-218.
51. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet 19:162-166.
52. Traskman L, Tybring G, Asberg M, Bertilsson L, Lantto B, Schalling D (1980) Cortisol in the CSF of depressed and suicidal patients. Arch Gen Psychiatry 37:761-767.
53. Von Bardeleben U, Holsboer F (1989) Cortisol response to a combined dexamethasone-hCRH challenge in patients with depression. J Neuroendocrinol 1:485-488.
54. Von Bardeleben U, Holsboer F (1991) Effect of age on the Cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol Psychiatry 29:1042-1050.
55. Von Bardeleben U, Holsboer F, Stalla GK, Miiller OA (1985) Combined administration of human corticotropin-releasing factor and lysine vasopressin induces Cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 37:1613-1618.
56. Whitnall MH, Mezey E, Gainer H (1985) Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles. Nature 317:248-250.
57. Zobel A, Yassouridis A, Friboes R-M, Holsboer F (1999) Prediction of medium-term outcome by Cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry. 156:949-951